The table below shows Cocrystal Pharma, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$225.00K
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$1.37M
$954.00K
$1.12M
$1.36M
$3.24M
$4.31M
SG&A
COCP annual revenue (10-K history)
Cocrystal Pharma, Inc. reported annual revenue of $2.01M for fiscal year 2020. That is down 69.3% from $6.56M in fiscal 2019. Figures come from the company's audited annual reports as filed with the SEC.